BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7197648)

  • 1. Bromocriptine compared to long-acting estrogens in lactation prevention: clinical efficacy, prolactin secretion and coagulation parameters.
    Leleux D; Merveille JJ; Capel P; Picard C; L'Hermite M
    Eur J Obstet Gynecol Reprod Biol; 1981 Oct; 12(4):235-42. PubMed ID: 7197648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of puerperal lactation by means of a single injection of bromocriptine retard.
    Valsamis J; Chavez H; Westelinck K; Haemers M; Francis G; L'Hermite M
    Eur J Obstet Gynecol Reprod Biol; 1987 May; 25(1):43-51. PubMed ID: 3595974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lactation by a long-acting bromocriptine.
    Peters F; Del Pozo E; Conti A; Breckwoldt M
    Obstet Gynecol; 1986 Jan; 67(1):82-5. PubMed ID: 3940343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of lactation comparing stilboestrol and bromocriptine (CB154).
    Ladipo OA; Ojo OA
    Niger Med J; 1979 Jan; 9(1):77-9. PubMed ID: 463344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of puerperal lactation by bromocriptine.
    Rolland R; Schellekens LA
    Acta Endocrinol Suppl (Copenh); 1978; 216():119-30. PubMed ID: 347857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocriptine in an injectable retard form for puerperal lactation suppression: comparison with Estandron prolongatum.
    Defoort P; Thiery M; Baele G; Clement D; Dhont M
    Obstet Gynecol; 1987 Dec; 70(6):866-9. PubMed ID: 3684122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactation inhibition by the dopamine agonist CV 205-502.
    van der Heijden PF; Kremer JA; Brownell J; Rolland R
    Br J Obstet Gynaecol; 1991 Mar; 98(3):270-6. PubMed ID: 1673628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. European Multicentre Study Group for Cabergoline in Lactation Inhibition.
    BMJ; 1991 Jun; 302(6789):1367-71. PubMed ID: 1676318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of recombinant human prolactin for treatment of poor puerperal lactation in a rat model.
    Yoneda N; Irahara M; Saito S; Uemura H; Aono T
    Eur J Endocrinol; 1995 Nov; 133(5):613-7. PubMed ID: 7581993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromocriptine mesylate for prevention of postpartum lactation.
    Duchesne C; Leke R
    Obstet Gynecol; 1981 Apr; 57(4):464-7. PubMed ID: 7243095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactation suppression.
    Kochenour NK
    Clin Obstet Gynecol; 1980 Dec; 23(4):1045-59. PubMed ID: 7004693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of cyclofenil in the inhibition of lactation. Efficacy compared to bromocriptine].
    Cingotti M; Magnin G
    Rev Fr Gynecol Obstet; 1986; 81(6-7):369-72. PubMed ID: 3094130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of four different dosages of injectable bromocriptine retard for puerperal ablactation.
    Duthie SJ; Fuk-Him DL; Fang AH; O'Hoy KM; Pak-Chung H
    Eur J Obstet Gynecol Reprod Biol; 1990 Mar; 34(3):223-8. PubMed ID: 2311809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the suppression of lactation and the influence on blood clotting with bromocriptine (CB 154) (Parlodel): a double blind comparison with diethylstilboestrol.
    Nilsen PA; Meling AB; Abildgaard U
    Acta Obstet Gynecol Scand; 1976; 55(1):39-44. PubMed ID: 766555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of puerperal lactation: evaluation of bromocriptine and placebo.
    Bhardwaj N
    Aust N Z J Obstet Gynaecol; 1979 Aug; 19(3):154-7. PubMed ID: 391210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of lactation by cyclofenil and bromocriptine.
    Thorbert G; Akerlund M
    Br J Obstet Gynaecol; 1983 Aug; 90(8):739-42. PubMed ID: 6411113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactation inhibition by a single injection of a new depot-bromocriptine.
    Kremer JA; Rolland R; van der Heijden PF; Schellekens LA; Vosmar MB; Lancranjan I
    Br J Obstet Gynaecol; 1990 Jun; 97(6):527-32. PubMed ID: 2378830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of several sexual steroids, 2-bromo-ergokryptin and lisurid-hydrogenmaleate an the postpartum concentration of serum prolactin and lactation (author's transl)].
    Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Michel E; Nevinny-Stickel J
    Geburtshilfe Frauenheilkd; 1977 Jun; 37(6):500-8. PubMed ID: 328335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early and late inhibition of lactation using bromocriptine. A comparative study (author's transl)].
    Chef R; Meert B
    J Gynecol Obstet Biol Reprod (Paris); 1978; 7(5):1003-12. PubMed ID: 570200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cabergoline versus bromocriptine in suppression of lactation after cesarean delivery.
    Giorda G; de Vincentiis S; Motta T; Casazza S; Fadin M; D'Alberton A
    Gynecol Obstet Invest; 1991; 31(2):93-6. PubMed ID: 2037265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.